The multi-state infant botulism outbreak related to ByHeart Whole Nutrition infant formula has reached 51 cases, according to ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors ...

Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease ...

The New York Times, attacked by President Donald Trump for reporting about his physical condition, said on Wednesday that it ...

The drugs are essentially laboratory-made versions of natural antibodies that help the immune system fight off RSV. The FDA ...

Among more than 4,000 patients with hormone receptor (HR)-positive disease, 3-year invasive disease-free survival (IDFS) ...

The FDA on Tuesday approved etuvetidigene autotemcel (Waskyra) as the first cell-based gene therapy for patients 6 months and ...

Suhasini Ravi, JD, MPH, is a senior associate at the Center for Health Policy and the Law at the O'Neill Institute in ...

A House hearing Wednesday on the topic of how technology can help lower healthcare costs was sidetracked almost immediately ...

The tool's positive predictive value for invasive bacterial infections was 6.9% (95% CI 4.8%-9.9%). Its negative predictive ...

At the San Antonio Breast Cancer Symposium (SABCS), investigators reported final phase I results of an alpha-lactalbumin (aLA ...